Skip to main content
To learn more about the Eversense CGM System, click here. COVID-19 Update
Eversense USA   Eversense Outside USA
To learn more about the Eversense CGM System, click here. COVID-19 Update
Home

Patient - Header - Main Menu - Desktop

  • Compatibility
  • User Guides
    • Eversense Users
    • Health Care Providers
  • Contact Us
  • About Us
  • Accessibility
Home

Mobile Main Navigation

  • Compatibility
  • User Guides
    • Clinic User
    • System Guides
  • CONTACT US
  • About Us

Provider Website
Payer Website

Eversense USA   Eversense Outside USA

Site Map

Paragraphs
Sitemap
 

SITE MAP

 
 
What is Eversense CGM?
  • Eversense Innovation
  • Eversense CGM system
    • Sensor
    • Transmitter
    • Mobile App
Why Eversense CGM?
  • Is Eversense right for you?
  • Eversense Benefits
How to Get Started?
  • Let’s get started
  • Switching to Eversense
  • Financial Assistance
Support
  • Resource Library
  • FAQs
  • Compatibility
  • Data Management
  • Get Support
Eversense Pioneers
 
Contact Us
 
About Us
  • How we started
  • Our team
  • What we believe
Footer Menu
  • EULA
  • Privacy Policy
  • Legal
  • Safety Information
 
Selector Class
sitemap-page-content
x

Right -Fixed Menu Home Page

  • Call
  • Email

Global - Footer - Top Menu

  • Need more information or support?
  • 844-SENSE4U (736-7348)
  • email us

Who we are

Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. Our mission is to help people with diabetes live their lives confidently and with ease.
Senseonics, Inc.

Eversense Diabetes Website

Eversense USA   Eversense Outside USA

Patient - Footer Menu - Column Four

  • CONTACT US
  • ABOUT US
    • How we started
    • What we believe
  • DMS LOGIN
DISCLAIMER

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MKT-5143-01-001 Rev 2

Footer Menu - Copyright

  • © 2019 Senseonics, Incorporated
  • EULA
  • Privacy Policy
  • Legal
  • Safety
  • Contact Us